Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6809 |
filingDate |
2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102405649-B1 |
titleOfInvention |
A composition for diagnosing severe patient of COVID-19 |
abstract |
The present invention relates to a composition for diagnosing severe patients with COVID-19. As described above, the present invention provides a variety of genes derived from macrophages, B cells and plasma cells of a subject; Alternatively, by comparing the expression level of the protein encoded by this, an antibody-dependent infection promotion phenomenon is induced, and it is possible to specifically diagnose a severe patient with coronavirus infection-19, in which B cells are activated as well as an excessive inflammatory response. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102578616-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220078552-A |
priorityDate |
2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |